Act Capital Management, LLC Leap Therapeutics, Inc. Transaction History

Act Capital Management, LLC

$72.5 Million
Q3 2022

A detailed history of Act Capital Management, LLC transactions in Leap Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 265,000 shares of LPTX stock, worth $519,400. This represents 0.32% of its overall portfolio holdings.

Number of Shares

265,000

Previous 265,000 -0.0%

Holding current value

$519,400

Previous $305,000 23.61%

% of portfolio

0.32%

Previous 0.43%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	BUY	$1.6 - $3.35 $64,000 - $134,000	40,000 Added 17.78%	265,000 $464,000
Q4 2021 Feb 03, 2022	BUY	$2.08 - $3.65 $145,600 - $255,500	70,000 Added 45.16%	225,000 $729,000
Q3 2021 Nov 16, 2021	BUY	$1.35 - $4.01 $28,350 - $84,210	21,000 Added 15.67%	155,000 $622,000
Q2 2021 Aug 16, 2021	BUY	$1.48 - $1.92 $198,320 - $257,280	134,000 New	134,000 $220,000

Others Institutions Holding LPTX

# of Institutions

Shares Held

265K

Call Options Held

Put Options Held

View Full List

About LEAP THERAPEUTICS, INC.

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $194M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

More about LPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Account

Act Capital Management, LLC Leap Therapeutics, Inc. Transaction History